The addition of Enbrel, a soluble TNFα-blocking antibody, did not inhibit the combination treatment-induced apoptosis in several glioblastoma cell lines, whereas Enbrel blocked apoptosis upon treatment with BV6 and TNFα, which was used as a positive control (Figure 4c). The gene discussed is TNF; the disease is glioblastoma.